-
1
-
-
0025146426
-
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by anti-thrombin III-independent inhibitors
-
August
-
Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by anti-thrombin III-independent inhibitors. J Clin Invest 1990; 86 (August): 385-91.
-
(1990)
J Clin Invest
, vol.86
, pp. 385-391
-
-
Weitz, J.I.1
Hudoba, M.2
Massel, D.3
Maraganore, J.4
Hirsh, J.5
-
2
-
-
0029087535
-
Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots
-
Prager NA, Abendschein DR, McKenzie CR, Eisenberg PR. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots. Circulation 1995; 92: 962-7.
-
(1995)
Circulation
, vol.92
, pp. 962-967
-
-
Prager, N.A.1
Abendschein, D.R.2
McKenzie, C.R.3
Eisenberg, P.R.4
-
3
-
-
0027199974
-
Importance of factor Xa in determining the procoagulant activity of whole-blood clots
-
May
-
Eisenberg PR, Siegel JE, Abdenschein DR, Miletich JP. Importance of factor Xa in determining the procoagulant activity of whole-blood clots. J Clin Invest 1993; 91 (May): 1877-83.
-
(1993)
J Clin Invest
, vol.91
, pp. 1877-1883
-
-
Eisenberg, P.R.1
Siegel, J.E.2
Abdenschein, D.R.3
Miletich, J.P.4
-
4
-
-
0029816710
-
Sustained inhibition of whole-blood clot procoagulant activity by inhibition of thrombus-associated factor Xa
-
McKenzie CR, Abendschein DR, Eisenberg PR. Sustained inhibition of whole-blood clot procoagulant activity by inhibition of thrombus-associated factor Xa. Arterioscler Thromb Vasc Biol 1996; 16: 1285-91.
-
(1996)
Arterioscler Thromb Vasc Biol
, vol.16
, pp. 1285-1291
-
-
McKenzie, C.R.1
Abendschein, D.R.2
Eisenberg, P.R.3
-
5
-
-
0026652586
-
Selective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons
-
Schaffer LW, Davidson JT, Vlasuk GP, Dunwiddie CT, Sigel PKS. Selective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons. Arteriosclerosis and Thrombosis 1992; 12: 879-85.
-
(1992)
Arteriosclerosis and Thrombosis
, vol.12
, pp. 879-885
-
-
Schaffer, L.W.1
Davidson, J.T.2
Vlasuk, G.P.3
Dunwiddie, C.T.4
Sigel, P.K.S.5
-
6
-
-
0029868652
-
Selective inhbition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis
-
Nicolini FA, Lee P, Malycky JL, Lefkovits J, Kottke-Marchant K, Plow EF. Selective inhbition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis. Blood Coagul Fibrin 1996; 7: 39-48.
-
(1996)
Blood Coagul Fibrin
, vol.7
, pp. 39-48
-
-
Nicolini, F.A.1
Lee, P.2
Malycky, J.L.3
Lefkovits, J.4
Kottke-Marchant, K.5
Plow, E.F.6
-
7
-
-
0025891319
-
Comparison of the in vivo anticoagulant properties of standard heparin and the highly selective factor Xa inhibitors antistasin and Tick Anticoagulant Peptide (TAP) in a rabbit model of venous thrombosis
-
Vlasuk GP, Ramjit D, Fujita T, Dunwiddie CT, Nutt EM, Smith DE. Comparison of the in vivo anticoagulant properties of standard heparin and the highly selective factor Xa inhibitors antistasin and Tick Anticoagulant Peptide (TAP) in a rabbit model of venous thrombosis. Thromb Haemost 1991; 65: 257-62.
-
(1991)
Thromb Haemost
, vol.65
, pp. 257-262
-
-
Vlasuk, G.P.1
Ramjit, D.2
Fujita, T.3
Dunwiddie, C.T.4
Nutt, E.M.5
Smith, D.E.6
-
8
-
-
0030856003
-
Antithrombotic efficacy of a recombinant nematode anticoagulant peptide (rNAP5) in canine models of thrombosis after single subcutaneous administration
-
Rebello SS, Blank HS, Rote WE, Vlasuk GP, Lucchesi BR. Antithrombotic efficacy of a recombinant nematode anticoagulant peptide (rNAP5) in canine models of thrombosis after single subcutaneous administration. J Pharm Exp Ther 1997; 283: 91-9.
-
(1997)
J Pharm Exp Ther
, vol.283
, pp. 91-99
-
-
Rebello, S.S.1
Blank, H.S.2
Rote, W.E.3
Vlasuk, G.P.4
Lucchesi, B.R.5
-
9
-
-
0028269097
-
DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa
-
Hara T, Yokoyama A, Ishihara H, Yokoyama Y, Nagahara T, Iwamoto M. DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa. Thromb Haemost 1994; 71: 314-9.
-
(1994)
Thromb Haemost
, vol.71
, pp. 314-319
-
-
Hara, T.1
Yokoyama, A.2
Ishihara, H.3
Yokoyama, Y.4
Nagahara, T.5
Iwamoto, M.6
-
10
-
-
0030097984
-
DX 9065, a novel, synthetic, selective and orally active inhibitor of factor Xa: In vitro and in vivo studies
-
Herbert JM, Bernat A, Dol R, Herault JP, Crepon B, Lormeau JC. DX 9065, a novel, synthetic, selective and orally active inhibitor of factor Xa: In vitro and in vivo studies. J Pharm Exp Ther 1996; 276: 1030-8.
-
(1996)
J Pharm Exp Ther
, vol.276
, pp. 1030-1038
-
-
Herbert, J.M.1
Bernat, A.2
Dol, R.3
Herault, J.P.4
Crepon, B.5
Lormeau, J.C.6
-
11
-
-
8544252429
-
SR 90107A/Org 31540, a novel anti-factor Xa antithrombotic agent
-
Herbert JM, Petitou M, Lormeau JC, Cariou R, Necciari J, Magnani HN. SR 90107A/Org 31540, a novel anti-factor Xa antithrombotic agent. Cardiovascular Drug Reviews 1997; 15(1): 1-26.
-
(1997)
Cardiovascular Drug Reviews
, vol.15
, Issue.1
, pp. 1-26
-
-
Herbert, J.M.1
Petitou, M.2
Lormeau, J.C.3
Cariou, R.4
Necciari, J.5
Magnani, H.N.6
-
12
-
-
0031964032
-
Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time
-
Sato K, Kawasaki T, Hisamichi N, Taniuchi Y, Hirayama F, Koshio H. Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time. Brit J Pharmacol 1998; 123: 92-6.
-
(1998)
Brit J Pharmacol
, vol.123
, pp. 92-96
-
-
Sato, K.1
Kawasaki, T.2
Hisamichi, N.3
Taniuchi, Y.4
Hirayama, F.5
Koshio, H.6
-
14
-
-
0030811328
-
Transient interruption of arterial thrombosis by inhibition of factor Xa results in long-term antithrombotic effects
-
Kotze HF, Lamprecht S, Badenhorst PN, Roodt JP, vanWyk V. Transient interruption of arterial thrombosis by inhibition of factor Xa results in long-term antithrombotic effects. Thromb Haemost 1997; 77: 1137-42.
-
(1997)
Thromb Haemost
, vol.77
, pp. 1137-1142
-
-
Kotze, H.F.1
Lamprecht, S.2
Badenhorst, P.N.3
Roodt, J.P.4
VanWyk, V.5
-
15
-
-
0028814459
-
Effect of inhibitors of factor Xa or platelet adhesion, heparin, and aspirin on platelet deposition in an atherosclerotic rabbit model of angioplasty injury
-
Lyle EM, Fujita T, Conner MW, Connolly TM, Vlasuk GP, Lynch JL, Jr. Effect of inhibitors of factor Xa or platelet adhesion, heparin, and aspirin on platelet deposition in an atherosclerotic rabbit model of angioplasty injury. J Pharmacol Toxicol Meth 1995, 33: 53-61.
-
(1995)
J Pharmacol Toxicol Meth
, vol.33
, pp. 53-61
-
-
Lyle, E.M.1
Fujita, T.2
Conner, M.W.3
Connolly, T.M.4
Vlasuk, G.P.5
Lynch J.L., Jr.6
|